Gland Pharma Limited (GLAND) — Cash Flow Reinvestment Rate
Gland Pharma Limited (GLAND) has a Cash Flow Reinvestment Rate of 0.33x as of September 2025, reinvesting Rs1.94 Billion (capex Rs1.94 Billion ) from operating cash flow of Rs5.93 Billion. See Gland Pharma Limited free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Gland Pharma Limited Cash Flow Reinvestment Rate (2017–2026)
Historical reinvestment intensity for Gland Pharma Limited across 10 annual periods. For the full cash flow conversion analysis, see Gland Pharma Limited operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for Gland Pharma Limited (2017–2026)
Year-by-year capital reinvestment analysis for Gland Pharma Limited. See how financially flexible is Gland Pharma Limited to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (INR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.72x | Rs8.90 Billion | Rs12.31 Billion | Rs4.91 Billion | ▼ -68.4% |
| 2025 | 2.28x | Rs20.89 Billion | Rs9.15 Billion | Rs3.85 Billion | ▲ +6.0% |
| 2024 | 2.15x | Rs21.47 Billion | Rs9.97 Billion | Rs3.90 Billion | ▼ -45.2% |
| 2023 | 3.93x | Rs14.31 Billion | Rs3.64 Billion | Rs2.23 Billion | ▲ +174.3% |
| 2022 | 1.43x | Rs11.34 Billion | Rs7.91 Billion | Rs5.22 Billion | ▼ -45.3% |
| 2021 | 2.62x | Rs15.86 Billion | Rs6.05 Billion | Rs2.29 Billion | ▲ +120.6% |
| 2020 | 1.19x | Rs8.33 Billion | Rs7.01 Billion | Rs1.95 Billion | ▼ -37.9% |
| 2019 | 1.91x | Rs3.54 Billion | Rs1.85 Billion | Rs1.36 Billion | ▲ +0.9% |
| 2018 | 1.90x | Rs3.83 Billion | Rs2.02 Billion | Rs851.75 Million | ▲ +118.1% |
| 2017 | 0.87x | Rs4.14 Billion | Rs4.76 Billion | Rs1.16 Billion | — |